Tag: European market
Biosimilars vs Generics: Why Europe Leads the US Market in 2026
Explore the divergent paths of biosimilar markets in Europe and the US. We compare regulatory frameworks, adoption rates, and future projections to explain why Europe leads and how the US is catching up.